SCHEMBL30279

SCHEMBL30279

CCC(C(=O)O)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656015 0.97 CHRM1 (0.36)
SCHEMBL69910 0.88
Ethylmalonate SCHEMBL107241 0.81
SCHEMBL8488441 0.80
SCHEMBL4318394 0.78 CHRM1 (0.52)
Ethylmalonate SCHEMBL108554 0.78 HDAC1 (0.43)
Ethylmalonate SCHEMBL9765245 0.78 HDAC1 (0.43)
Ethylmalonate SCHEMBL9118935 0.78 HDAC1 (0.43)
Ethylmalonate SCHEMBL5236397 0.78 HDAC1 (0.43)
Ethylmalonate SCHEMBL3157979 0.78 HDAC1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112851494-A Preparation method of 1-pyrenebutyric acid 苏州昊帆生物股份有限公司 2021-05-28 CN claimed
EP-4480480-A2 SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF Bayer AG (DE) 2024-12-25 EP disclosed
EP-4188551-B1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF BAYER AG (DE) 2024-12-18 EP disclosed
EP-4188929-B1 SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF BAYER AG (DE) 2024-10-02 EP disclosed
US-20230365554-A1 SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-16 US disclosed
US-20230322767-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF THE BROAD INSTITUTE, INC. 2023-10-12 US disclosed
EP-4188929-A1 SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF Bayer Aktiengesellschaft (DE) 2023-06-07 EP disclosed
EP-4188551-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF Bayer Aktiengesellschaft (DE) 2023-06-07 EP disclosed
US-20220218676-A1 CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2022-07-14 US disclosed
EP-3519416-B1 CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS MGLUR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME (US) 2021-03-31 EP disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed
US-6153705-A CHAIN-END FUNCTIONALIZED BY ALKYL XANTHATES. RHODIA CHIMIE (FR) 2000-11-28 US disclosed
EP-0652208-B1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity ONO PHARMACEUTICAL CO (JP) 1998-01-14 EP disclosed
EP-0652208-A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity ONO PHARMACEUTICAL CO., LTD. (JP) 1995-05-10 EP disclosed
US-4336380-A FOR USE AS HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1982-06-22 US disclosed
EP-0034951-A2 Photographic emulsions and elements containing blocked 5-pyrazolone magenta dye-forming couplers EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1981-09-02 EP disclosed
US-4276417-A TREATMENT OF VASCULAR-CONDITION HYPERTENSION HOFFMANN-LA ROCHE INC. (US) 1981-06-30 US disclosed